Genenta Science S.p.A. Payments to Acquire Marketable Securities
Genenta Science S.p.A. (GNTA) reported Payments to Acquire Marketable Securities of EUR 33.17 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-04-01
| Period end | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|
| 2025-12-31 | 33.17M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 12.42M EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | 16.38M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 9.00M EUR 6-K · filed 2025-10-10 | |
| 2023-12-31 | 14.88M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 9.99M EUR 6-K · filed 2024-10-29 |